SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-033059
Filing Date
2014-05-01
Accepted
2014-05-01 08:50:45
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-8947_110q.htm 10-Q 781291
2 EX-31.1 a14-8947_1ex31d1.htm EX-31.1 12574
3 EX-31.2 a14-8947_1ex31d2.htm EX-31.2 13160
4 EX-32.1 a14-8947_1ex32d1.htm EX-32.1 8474
  Complete submission text file 0001104659-14-033059.txt   6369170

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cldx-20140331.xml EX-101.INS 707991
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20140331.xsd EX-101.SCH 74970
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20140331_cal.xml EX-101.CAL 70602
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20140331_lab.xml EX-101.LAB 1244051
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20140331_pre.xml EX-101.PRE 565656
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20140331_def.xml EX-101.DEF 345287
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 14802151
SIC: 2835 In Vitro & In Vivo Diagnostic Substances